Michael M. Poe

1.4k total citations
42 papers, 961 citations indexed

About

Michael M. Poe is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Michael M. Poe has authored 42 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cellular and Molecular Neuroscience, 23 papers in Molecular Biology and 8 papers in Cognitive Neuroscience. Recurrent topics in Michael M. Poe's work include Neuroscience and Neuropharmacology Research (25 papers), Pharmacological Receptor Mechanisms and Effects (13 papers) and Receptor Mechanisms and Signaling (8 papers). Michael M. Poe is often cited by papers focused on Neuroscience and Neuropharmacology Research (25 papers), Pharmacological Receptor Mechanisms and Effects (13 papers) and Receptor Mechanisms and Signaling (8 papers). Michael M. Poe collaborates with scholars based in United States, Austria and Serbia. Michael M. Poe's co-authors include James M. Cook, Andrew J. Wiemer, Anthony A. Grace, Chia‐Hung Christine Hsiao, Leggy A. Arnold, Guanguan Li, Kathryn Gill, Miroslav M. Savić, Jeffrey M. Witkin and Rok Cerne and has published in prestigious journals such as Nature Neuroscience, Brain Research and The FASEB Journal.

In The Last Decade

Michael M. Poe

42 papers receiving 948 citations

Peers

Michael M. Poe
Philippe Pichat France
Katherine M. Nautiyal United States
M Baez United States
Mireille Daigle Canada
Melvyn Baez United States
Michael A. Ackley United States
Vez Repunte‐Canonigo United States
Gabriela B. Acosta Argentina
Anti Kalda Estonia
Morten S. Thomsen Denmark
Philippe Pichat France
Michael M. Poe
Citations per year, relative to Michael M. Poe Michael M. Poe (= 1×) peers Philippe Pichat

Countries citing papers authored by Michael M. Poe

Since Specialization
Citations

This map shows the geographic impact of Michael M. Poe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Poe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Poe more than expected).

Fields of papers citing papers by Michael M. Poe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M. Poe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Poe. The network helps show where Michael M. Poe may publish in the future.

Co-authorship network of co-authors of Michael M. Poe

This figure shows the co-authorship network connecting the top 25 collaborators of Michael M. Poe. A scholar is included among the top collaborators of Michael M. Poe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael M. Poe. Michael M. Poe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poe, Michael M., et al.. (2022). Synthesis and Metabolism of BTN3A1 Ligands: Studies on Diene Modifications to the Phosphoantigen Scaffold. ACS Medicinal Chemistry Letters. 13(2). 164–170. 8 indexed citations
2.
3.
4.
Poe, Michael M., et al.. (2020). Synthesis and Metabolism of BTN3A1 Ligands: Studies on Modifications of the Allylic Alcohol. ACS Medicinal Chemistry Letters. 12(1). 136–142. 3 indexed citations
5.
Acuña, Mario A., Elena Neumann, William T. Ralvenius, et al.. (2020). Mice lacking spinal α2GABAA receptors: Altered GABAergic neurotransmission, diminished GABAergic antihyperalgesia, and potential compensatory mechanisms preventing a hyperalgesic phenotype. Brain Research. 1741. 146889–146889. 9 indexed citations
6.
Poe, Michael M., et al.. (2019). Probing the Ligand-Binding Pocket of BTN3A1. Journal of Medicinal Chemistry. 62(14). 6814–6823. 14 indexed citations
7.
Li, Jin, et al.. (2019). Regulation of the Notch-ATM-abl axis by geranylgeranyl diphosphate synthase inhibition. Cell Death and Disease. 10(10). 733–733. 7 indexed citations
8.
Cerne, Rok, Scott D. Gleason, Jeffrey M. Schkeryantz, et al.. (2018). An antidepressant-related pharmacological signature for positive allosteric modulators of α2/3-containing GABA A receptors. Pharmacology Biochemistry and Behavior. 170. 9–13. 12 indexed citations
9.
Li, Guanguan, Michael Rajesh Stephen, Michael M. Poe, et al.. (2018). Synthesis of chiral GABAA receptor subtype selective ligands as potential agents to treat schizophrenia as well as depression. ARKIVOC. 2018(4). 158–182. 12 indexed citations
10.
Ernst, Margot, Rok Cerne, Mark Wakulchik, et al.. (2018). Negative allosteric modulation of alpha 5-containing GABAA receptors engenders antidepressant-like effects and selectively prevents age-associated hyperactivity in tau-depositing mice. Psychopharmacology. 235(4). 1151–1161. 19 indexed citations
11.
Witkin, Jeffrey M., Rok Cerne, Mark Wakulchik, et al.. (2017). Further evaluation of the potential anxiolytic activity of imidazo[1,5- a ][1,4]diazepin agents selective for α2/3-containing GABA A receptors. Pharmacology Biochemistry and Behavior. 157. 35–40. 17 indexed citations
12.
Fischer, Bradford D., Margot Ernst, Michael M. Poe, et al.. (2017). Pharmacological and antihyperalgesic properties of the novel α2/3 preferring GABAA receptor ligand MP-III-024. Brain Research Bulletin. 131. 62–69. 22 indexed citations
13.
Li, Guanguan, et al.. (2017). Abuse-related effects of subtype-selective GABAA receptor positive allosteric modulators in an assay of intracranial self-stimulation in rats. Psychopharmacology. 234(14). 2091–2101. 12 indexed citations
14.
Stephen, Michael Rajesh, Michael M. Poe, Guanguan Li, et al.. (2016). Optimization of substituted imidazobenzodiazepines as novel asthma treatments. European Journal of Medicinal Chemistry. 126. 550–560. 17 indexed citations
15.
Poe, Michael M., et al.. (2016). Characterization of GABAA receptor ligands with automated patch-clamp using human neurons derived from pluripotent stem cells. Journal of Pharmacological and Toxicological Methods. 82. 109–114. 14 indexed citations
16.
Piantadosi, Sean C., Beverly J. French, Michael M. Poe, et al.. (2016). Sex-Dependent Anti-Stress Effect of an α5 Subunit Containing GABAA Receptor Positive Allosteric Modulator. Frontiers in Pharmacology. 7. 446–446. 52 indexed citations
17.
Clayton, Terry, Michael M. Poe, Sundari Rallapalli, et al.. (2015). A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model. PubMed. 2015. 1–54. 40 indexed citations
18.
Rowlett, James K., Angela N. Duke, Donna M. Platt, et al.. (2015). Evidence for sedative effects of benzodiazepines involving unexpected GABA A receptor subtypes. Drug and Alcohol Dependence. 156. e194–e194. 1 indexed citations
19.
Obradović, Aleksandar Lj., Michael M. Poe, Joachim Ramerstorfer, et al.. (2014). Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: The approximated activation of receptor subtypes may explain behavioral effects. Brain Research. 1554. 36–48. 15 indexed citations
20.
Drexler, Berthold, Shengming Huang, Michael M. Poe, et al.. (2013). Enhancing the function of alpha5-subunit-containing GABAA receptors promotes action potential firing of neocortical neurons during up-states. European Journal of Pharmacology. 703(1-3). 18–24. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philippe Pichat Breakdown of academic impact, for papers by Katherine M. Nautiyal Breakdown of academic impact, for papers by M Baez Breakdown of academic impact, for papers by Mireille Daigle Breakdown of academic impact, for papers by Melvyn Baez Breakdown of academic impact, for papers by Michael A. Ackley Breakdown of academic impact, for papers by Vez Repunte‐Canonigo Breakdown of academic impact, for papers by Gabriela B. Acosta Breakdown of academic impact, for papers by Anti Kalda Breakdown of academic impact, for papers by Morten S. Thomsen
Rankless by CCL
2026